where is semaglutide from Understanding How Works: A Comprehensive Review New obesity drug semaglutide is
Description
It has published positive phase 2 trials in the US and is entering phase 3 trials for obesity
If approved, you receive a REMPE electronic prescription (PDF file) in your Hi-Doctor account and by email within 24 hours
Patients with normal baseline markers may achieve goals faster, though individual response varies significantly regardless of starting metabolic status
When prescribed for this indication, it is generally eligible for Part D coverage, subject to your plan's formulary and tier placement
